Rujittika Mungmunpuntipantip1, Viroj Wiwanitkit2. 1. Consultant Unit, Private Acdemic Consultant, Bangkok Thailand. Electronic address: rujittika@gmail.com. 2. Dr DY Patil University, Pune, India.
Dear Editor, we read with interest the paper “COVID-19 Vaccine-Associated Subclinical Axillary Lymphadenopathy on Screening Mammogram” by Raj et al. (1) where the authors concluded that women who have received either mRNA COVID-19 vaccines may benefit from scheduling their screening mammogram at least 8 weeks after the vaccination. We concur that lymphadenopathy after COVID-19 vaccination might cause a problem in interpreting the mammogram and that having the mammogram before vaccination is useful.However, during the present pandemic, mass vaccination is needed, and it is often difficult to schedule a timely appointment for a mammogram. In cases in which it is not possible to have a prevaccination mammogram, a mammogram after vaccination is useful. Waiting for 10 weeks, similar to that recommended for nuclear imaging studies (2), might be appropriate. If the case is urgent, aiming at diagnostic not screening, the mammogram should be done without delay.
AUTHORS CONTRIBUTIONS
RM 50 % -
1a Substantial contributions to study conception and design.1b. Substantial contributions to acquisition of data.1c. Substantial contributions to analysis and interpretation of data.2. Drafting the article or revising it critically for important intellectual content.3. Final approval of the version of the article to be published.
VW 50% -
1a Substantial contributions to study conception and design.1b. Substantial contributions to acquisition of data.1c. Substantial contributions to analysis and interpretation of data.2. Drafting the article or revising it critically for important intellectual content.3. Final approval of the version of the article to be published.